QUOTE AND NEWS
StreetInsider.com  Nov 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Novadel+Pharma+Inc.+%28NVD%29+Posts+Q3+Loss+of+2c%2C+In-Line+with+Views/5114685.html for the full story.
Business Wire  Nov 16  Comment 
NovaDel Pharma Inc. (the “Company”) (NYSE AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported financial results for its third quarter and nine months ended September
Business Wire  Nov 16  Comment 
NovaDel Pharma Inc. (NYSE AMEX: NVD) today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture
Business Wire  Nov 5  Comment 
NovaDel Pharma Inc. (NYSE AMEX: NVD), today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled “Buccal, Polar and Non-polar
Business Wire  Oct 27  Comment 
NovaDel Pharma Inc., (NYSE AMEX: NVD) has entered into a licensing agreement with privately-held Mist Acquisition, LLC to manufacture and commercialize the NitroMist® lingual spray version of nitroglycerine, a widely-prescribed and leading
Business Wire  Sep 2  Comment 
NovaDel Pharma Inc. (NYSE AMEX: NVD) announced that an article titled “Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine” was published online on June 22, 2009 in the peer-reviewed journal Headache: The
StreetInsider.com  Jun 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/NovaDel+Pharma+%28NVD%29+Receives+Commitment+From+Seaside+88+to+Purchase+Up+To+13+Million+Shares/4760112.html for the full story.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
NVD AT A GLANCE
P/E -2.25 
EV/EBITDA -2.62 
ROA -142.6%VERY LOW
ROE -1337.9%VERY LOW
Debt to Equity -1.31 
Current Ratio 0.218VERY LOW
Interest Coverage Ratio -5.70AVG
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki